home

Relmada Therapeutics Launches Pharmaceutical Armada Against Chronic Pain and Opioid Abuse

Commentsthelifesciencesreport2016-04-22 10:37 Read   81

To treat chronic pain without risk of addiction is to straddle a knife's edge.

Cancer drugs help Roche beat expectations in first quarter

Commentspmlive2016-04-22 10:01 Read   73

Strong sales of Roche's top three drugs - backed up by strong growth for new launches - helped the Swiss pharma group top analyst projections in the first quarter.

FDA lambasts Sri Krishna Pharma plant in new warning letter

CommentsSri Krishna2016-04-21 14:20 Read   78

Data manipulation and integrity issues have struck again as the FDA called out India's Sri Krishna Pharmaceuticals in a newly published warning letter, highlighting several concerns it's noted for years at the drugmaker's operation.

Treato Finds DTC Pharma TV Advertisements Have Little Influence

Commentsprnewswire2016-04-21 13:56 Read   73

Timed to the DTC Perspectives conference kicking off this week, Treato, the single largest source of online consumer insights on healthcare, released their annual survey on consumers' opinions of DTC advertisements.

Remicade safe from biosimilar competition this year, says J&J

Commentspmlive2016-04-21 13:23 Read   83

Johnson & Johnson does not expect any biosimilar competition to its top product Remicade in the US this year, according to the firm's chief financial officer Dominic Caruso.

Statement on Review of NIH Sterile Production Facilities

CommentsNIH2016-04-21 10:42 Read   71

In light of serious problems identified in the NIH Clinical Center Pharmaceutical Development Section last year, NIH launched a multifaceted effort to ensure that processes for patient safety and quality of care at the hospital are of the highest standards.

Similar RA disease response seen with abatacept, adalimumab at more than 2 years

Commentshealio2016-04-20 11:12 Read   207

With background methotrexate treatment, similar response rates were seen between patients with rheumatoid arthritis who were treated with the biologic medications abatacept or adalimumab, according to recently published data.

Weekly Market Movers: Asia Analysis (to 18 Apr 2016)

Commentsepvantage2016-04-20 10:50 Read   77

EvaluatePharma’s EventAnalyzer Asia delivers a weekly round up of key events driving company valuations in Asia.

Ready Or Not: Next Alzheimer’s Drugs Might Strain Health Systems

Commentsxconomy2016-04-20 10:36 Read   71

By 2029, more than 20 percent of people in the United States will be over the age of 65. That’s why the race to find effective treatments for Alzheimer’s disease feels urgent.

'Palliative Care' Gets a Bad Rap, Study Finds

CommentsDRUGS2016-04-20 10:12 Read   75

The term "palliative care" triggers negative feelings among many cancer patients, and needs "rebranding," researchers say.

Americans' Longer Life = Poorer Health

CommentsDRUGS2016-04-20 10:04 Read   67

Americans are living longer, but those extra years may include poor health or a disability, a new study finds.

Helminths, parasites and flukes, oh my! A review of treatments for common NTDs

Commentshealio2016-04-19 17:18 Read   75

Neglected tropical diseases, or NTDs, are a group of chronic, debilitating, communicable diseases that predominantly affect those living in poverty in developing countries in Latin America, Africa and South Asia.